Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Canada
  5. Columbia Care Inc.
  6. News
  7. Summary
    CCHW   CA1973091079


Delayed Quote. Delayed CANADIAN NATIONAL STOCK EXCHANGE - 09/21 03:59:33 pm
5.15 CAD   +3.62%
09/09COLUMBIA CARE : Celebrates the Start of Whole Flower Cannabis Sales in Virginia
09/02COLUMBIA CARE : to Rebrand as Cannabist in Florida
09/02Columbia Care to Rebrand as Cannabist in Florida
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Columbia Care : Announces Launch of West Virginia Market Operations

07/09/2021 | 09:29am EDT

Company Leads the Market with Largest-Scale Cultivation in the State

Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis products, today announced it has received approval from the Office of Medical Cannabis, West Virginia Department of Health and Human Resources, to begin cultivation operations in the state at its facility in Falling Waters.

“We are excited to begin cultivation in West Virginia and be one step closer to providing relief to the patients who need it,” said Nicholas Vita, CEO of Columbia Care. “Our ability to begin operations solidifies our position as a leader in the state. As we begin design of Phase 2 of our buildout, we will add more square feet to our facilities to continue to meet the demand of the medical program in West Virginia.”

As one of only 10 provisionally licensed cultivators in West Virginia, Columbia Care’s facility will utilize the maximum available cultivation space permitted under state regulation. The Company has begun developing all five of its medical dispensaries across West Virginia, which will support the growing community of more than 2,300 enrolled patients in the state’s medical program.

About Columbia Care

Columbia Care is one of the largest and most experienced cultivators, manufacturers and providers of cannabis products and related services, with licenses in 18 US jurisdictions and the EU. Columbia Care currently operates 126 facilities1 including 95 dispensaries and 31 cultivation and manufacturing facilities. Columbia Care is one of the original providers of medical cannabis in the U.S. and continues to deliver industry-leading products and services. The company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. Through its dispensary network, the company offers products spanning flower, edibles, oils, and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, Classix, Plant Sugar, Press, Amber and Platinum Label CBD. For more information on Columbia Care, please visit www.col-care.com.

Caution Concerning Forward-Looking Statements

This press release contains certain statements that constitute forward-looking information within the meaning of applicable securities laws (“forward-looking statements”). Statements concerning Columbia Care’s objectives, goals, strategies, priorities, intentions, plans, beliefs, expectations and estimates, and the business, operations, financial performance and condition of Columbia Care are forward-looking statements. The words “believe”, “expect”, “anticipate”, “estimate”, “intend”, “may”, “will”, “would”, “could”, “should”, “continue”, “plan”, “goal”, “objective”, and similar expressions and the negative of such expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

Forward-looking statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments. These statements speak only as at the date they are made and are based on information currently available and on the then current expectations. Holders of securities of the Company are cautioned that forward-looking statements are not based on historical facts but instead are based on reasonable assumptions and estimates of management of the Company at the time they were provided or made and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements, including, but not limited to, risks and uncertainties related to: the available funds of the Company and the anticipated use of such funds; the availability of financing opportunities; legal and regulatory risks inherent in the cannabis industry; risks associated with economic conditions, dependence on management and currency risk; risks relating to U.S. regulatory landscape and enforcement related to cannabis, including political risks; risks relating to anti-money laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the cannabis industry; risks related to contracts with third-party service providers; risks related to the enforceability of contracts; reliance on the expertise and judgment of senior management of the Company, and ability to retain such senior management; risks related to proprietary intellectual property and potential infringement by third parties; risks relating to the management of growth; increasing competition in the industry; risks inherent in an agricultural business; risks relating to energy costs; risks associated to cannabis products manufactured for human consumption including potential product recalls; reliance on key inputs, suppliers and skilled labor; cybersecurity risks; ability and constraints on marketing products; fraudulent activity by employees, contractors and consultants; tax and insurance related risks; risks related to the economy generally; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcement of judgments and effect service outside of Canada; risks related to future acquisitions or dispositions; sales by existing shareholders; limited research and data relating to cannabis; as well as those risk factors discussed under "Risk Factors" in Columbia Care’s Annual Information Form dated March 31, 2021 and filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com, in the Company's Annual Information Form, and as described from time to time in documents filed by the Company with Canadian securities regulatory authorities.

The purpose of forward-looking statements is to provide the reader with a description of management's expectations, and such forward-looking statements may not be appropriate for any other purpose. In particular, but without limiting the foregoing, disclosure in this press release as well as statements regarding the Company's objectives, plans and goals, including future operating results and economic performance may make reference to or involve forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. A number of factors could cause actual events, performance or results to differ materially from what is projected in the forward-looking statements. No undue reliance should be placed on forward-looking statements contained in this press release. Such forward-looking statements are made as of the date of this press release. Columbia Care undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. The Company's forward-looking statements are expressly qualified in their entirety by this cautionary statement.

1 Pro forma facilities either open or under development; includes facilities where Columbia Care provides consultative services pursuant to the terms of a management services arrangement

ę Business Wire 2021
All news about COLUMBIA CARE INC.
09/09COLUMBIA CARE : Celebrates the Start of Whole Flower Cannabis Sales in Virginia
09/02COLUMBIA CARE : to Rebrand as Cannabist in Florida
09/02Columbia Care to Rebrand as Cannabist in Florida
08/16COLUMBIA CARE : Expands New Jersey Footprint with New Dispensary in Deptford, Bringing Sca..
08/16Columbia Care Inc. Expands New Jersey Footprint with New Dispensary in Deptford, Bringi..
08/16Columbia Care Inc. acquired Corsa Verde LLC for approximately $2.7 million.
08/12Columbia Care Inc. Reaffirms Revenue Guidance for 2021
08/12COLUMBIA CARE : Reports Record Second Quarter 2021 Results
08/12Columbia Care Inc. Reports Unaudited Consolidated Earnings Results for the Second Quart..
08/10COLUMBIA CARE : Commences Adult Use Sales at Downtown Boston Dispensary
More news
Financials (USD)
Sales 2021 516 M - -
Net income 2021 -17,6 M - -
Net Debt 2021 235 M - -
P/E ratio 2021 -100x
Yield 2021 -
Capitalization 1 469 M 1 470 M -
EV / Sales 2021 3,30x
EV / Sales 2022 2,04x
Nbr of Employees -
Free-Float 58,9%
Duration : Period :
Columbia Care Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Mean consensus BUY
Number of Analysts 11
Last Close Price 4,02 $
Average target price 11,46 $
Spread / Average Target 185%
EPS Revisions
Managers and Directors
Nicholas Keane Vita Vice Chairman & Chief Executive Officer
Michael Livingstone Chief Financial Officer, VP & Controller
Michael Abbott Executive Chairman
Rosemary Mazanet Chief Scientific Officer
David James Hart Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
COLUMBIA CARE INC.-35.71%1 420
AYR WELLNESS INC.-9.59%1 261